4.5 Article

Orbitofrontal volume reductions during emotion recognition in patients with major depression

Journal

JOURNAL OF PSYCHIATRY & NEUROSCIENCE
Volume 35, Issue 5, Pages 311-320

Publisher

CMA-CANADIAN MEDICAL ASSOC
DOI: 10.1503/jpn.090076

Keywords

-

Funding

  1. Eli Lilly International Foundation
  2. AstraZeneca
  3. Bristol-Myers Squibb
  4. Eli Lilly
  5. Eisai
  6. GlaxoSmithKline
  7. Janssen Cilag
  8. Lundbeck
  9. Merck
  10. Novartis
  11. Organon
  12. Pfizer
  13. Sanofi Aventis
  14. Sepracor
  15. Servier
  16. Wyeth

Ask authors/readers for more resources

Background: Major depressive disorder is associated with both structural and functional alterations in the emotion regulation network of the central nervous system. The relation between structural and functional changes is largely unknown. Therefore, we sought to determine the relation between structural differences and functional alterations during the recognition of emotional facial expressions. Methods: We examined 13 medication-free patients with major depression and 15 healthy controls by use of structural T-1-weighted high-resolution magnetic resonance imaging (MRI) and functional MRI during 1 session. We set the statistical threshold for the analysis of imaging data to p < 0.001 (uncorrected). Results: As shown by voxel-based morphometry, depressed patients had reductions in orbitofrontal cortex volume and increases in cerebellar volume. Additionally, depressed patients showed increased activity during emotion recognition in the middle frontal cortex, caudate nucleus, precuneus and lingual gyrus. Within this cerebral network, the orbitofrontal volumes were negatively correlated in depressed patients but not in healthy controls with changes in blood oxygen level-dependent signal in the middle frontal gyrus, caudate nucleus, precuneus and supplementary motor area. Limitations: Our results are limited by the relatively small sample size. Conclusions: This combined functional and structural MRI study provides evidence that the orbitofrontal cortex is a key area in major depression and that structural changes result in functional alterations within the emotional circuit. Whether these alterations in the orbitofrontal cortex are also related to persistent emotional dysfunction in remitted mental states and, therefore, are related to the risk of depression needs further exploration.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available